Status:

UNKNOWN

A Clinical Trial to Evaluate the Effectiveness of Lactobacillus Reuteri for Periodontitis in a Chinese Population

Lead Sponsor:

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborating Sponsors:

West China College of Stomatology

Peking University Third Hospital

Conditions:

Periodontitis

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The aim of this study is to determine the efficacy of application of Lactobacillus Reuteri probiotics therapy on clinical improvement and on microbial shift in Chinese periodontitis patients.

Detailed Description

Periodontitis is a chronic inflammatory disease with a prevalence of 80% in Chinese adults, which is the main cause of tooth loss in adults. Periodontitis has also been demonstrated to be a risk facto...

Eligibility Criteria

Inclusion

  • 18-65 years of age
  • Patients diagnosed with periodontitis clinically evident according to International Classification of Periodontal Diseases (2017) with periodontal probing depth ≥4mm, attachment loss of the most severe site in the adjacent area ≥3mm, and imaging bone loss more than 1/3 of the root length
  • Natural teeth remaining in the mouth≥ 14

Exclusion

  • Patients with any other systemic diseases which likely to alter the progression and course of periodontitis, except coronary disease, diabetes or hypertension.
  • Patients with aggressive periodontitis.
  • Patients who received any periodontal treatment in the past 6 months
  • Pregnant or lactating women
  • Patients who smoke
  • Patients in the acute phase of an infectious disease
  • Patients taking bisphosphonate mediation
  • Patients who are on any probiotic, anticoagulants or antibiotic supplements for the past 3 months
  • Patients allergic to lactate products
  • Patients who are deemed uncooperative

Key Trial Info

Start Date :

December 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 30 2021

Estimated Enrollment :

880 Patients enrolled

Trial Details

Trial ID

NCT04129684

Start Date

December 1 2019

End Date

November 30 2021

Last Update

May 12 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Second Affiliated Hospital, School of Medicine

Hangzhou, Zhejiang University, China, 310002